Biosurgery Market

Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023

Report Code: MD 3554 Jul, 2018, by marketsandmarkets.com

[314 Pages Report] The overall biosurgery market is expected to grow from USD 10.67 billion in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 15.58 billion by 2023. The rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities, and growing need for effective blood loss management in patients which, in turn, help in the growth of the market. The biosurgery market is expanding with the emergence of new products and applications. These biosurgery product being used in many applications such gynecological surgery, general surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, urological surgery, reconstructive surgery and thoracic surgery. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

Market Dynamics

Drivers

  • Rising geriatric population
  • Increasing volume of surgeries and prevalence of severe trauma injuries
  • Strong focus on R&D leading to the launch of new and advanced products
  • Rising need for effective blood loss management in patients

Restraints

  • High price of biosurgery products and rising cost of surgical procedures

Opportunities

  • Untapped emerging markets

Challenge

  • Stringent regulatory framework
  • Requirement of skilled personnel for the effective use of biosurgery products

USE OF BIOSUREGERY PRODUCTS IN SURGICAL PROCEDURES DRIVE THE GLOBAL BIOSURGERY MARKET

Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones. Some commonly used biosurgery products include surgical sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents. These products are intended to control blood loss, aid wound healing, and assist the healing of surgical sites during various surgeries. Therefore, the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities, and growing need for effective blood loss management in patients drives the growth of biosurgery market.

TECHNOLOGICAL INNOVATION - OPENING NEW AVENUES FOR GROWTH IN BIOSURGERY MARKET

Biosurgery Market

Biosurgery Market

The following are the major objectives of the study.

  • To define, describe, and forecast the biosurgery market by product, application, and region
  • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the biosurgery market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the biosurgery market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, and patent or regulatory approvals of key players in the biosurgery market

During this research study, major players operating in the biosurgery market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Biosurgery Market

To know about the assumptions considered for the study, download the pdf brochure

The biosurgery market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the biosurgery market are Baxter International (US), C.R. Bard (US), Johnson & Johnson (US), Medtronic (Ireland), Sanofi (France), B. Braun (Germany), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Hemostasis (US), Integra Lifesciences (US), Cohera Medical (US), Pfizer (US), and CSL Limited (Australia).

Major Market Developments

  • Integra LifeSciences Holdings Corporation (US) launched the Codman Specialty Surgical product portfolio in April 2018.
  • Baxter International Inc. (US) enhanced its FLOSEAL and TISSEEL hemostatic product OFFERINGS in April 2017.
  • In September 2017, Medtronic launched the Infuse Bone Graft, which is a recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge carrier (ACS). It helps stimulate natural bone formation.

Target Audience

  • Biosurgery product manufacturers
  • Biosurgery product distributors and suppliers
  • Healthcare providers
  • Medical device manufacturers
  • Research institutes and academic centers
  • Contract research organizations (CROs)
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Report Scope

Biosurgery Market, By Product

  • Surgical Sealants and Adhesives
    • Natural/Biological Sealants and Adhesives, By Type
      • Fibrin Sealants
      • Collagen-based Sealants
      • Gelatin-based Sealants
      • Albumin-based Sealants
      • Other Natural/Biological Sealants (Polysaccharide-based Sealants such as Chitosan-based, Dextran-based, and Chondroitin-based Sealants and Adhesives)
    • Natural/Biological Sealants and Adhesives, By Origin
      • Human Blood-based
      • Animal-based Sealants
    • Synthetic/Semi-synthetic Sealants and Adhesives
      • Cyanoacrylates
      • Polymeric Hydrogels
      • Urethane-based Sealants
      • Others (Polyglycerol Sebacate and Lactic Acid-based Sealants)
  • Hemostatic Agents
    • Thrombin-based
    • Oxidized Regenerated Cellulose-based Hemostats
    • Combination Hemostats
  • Adhesion Barriers
    • Synthetic Adhesion Barriers
      • Hyaluronic Acid
      • Regenerated Cellulose
      • Polyethylene Glycol (PEG)
      • Other Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
      • Collagen and Protein
      • Fibrin-based
  • Soft-tissue Attachments
    • Synthetic Meshes
    • Biological Meshes
      • Allografts
      • Xenografts
  • Bone-graft Substitutes
    • Demineralized Bone Matrix (DBM)
    • Synthetic Bone Grafts
    • Bone Morphogenetic Proteins (BMP)
    • Others Bone-graft Substitutes

Biosurgery Market, By Application

  • Gynecological Surgery
  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Urological Surgery
  • Reconstructive Surgery
  • Thoracic Surgery

Biosurgery Market, by Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
  • The Middle East and Africa

Critical questions which the report answers

  • What are new application areas which the biosurgery companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further country-wise breakdown of the market in Rest of APAC and Rest of Latin America based on product

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The overall biosurgery market is expected to grow from 15.58 billion by 2023 from USD 11.36 billion in 2018, at a CAGR of 6.5%. The rising geriatric population; increase in the volume of surgeries and sports-related and trauma injuries; increasing clearance of biosurgery products by regulatory authorities; and growing need for effective blood loss management in patients are the key factors driving the growth of this market.

Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones. Some commonly used biosurgery products include surgical sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents. These products are intended to control blood loss, aid wound healing, and assist the healing of surgical sites during various surgeries.

The biosurgery market has been segmented, on the basis of product into bone-graft substitutes, soft-tissue attachments, surgical sealants and adhesives, hemostatic agents, adhesion barriers, and staple-line reinforcement agents. The market for surgical sealants and adhesives is expected to grow at the highest CAGR between 2018 and 2023 The increasing demand for polymeric hydrogel-based sealants contribute to the rapid growth of the market.

The biosurgery market in APAC is expected to grow at the highest CAGR during the forecast period. APAC is the fastest-growing market for biosurgery products. The rising healthcare expenditure, growing volume of surgical procedures, and rising need for effective blood loss management, has increased the growth of biosurgery market in this region. The increasing penetration of biosurgery products and the influx of global players, along with the emergence of native players, are contributing to the growth of the market. As a result, APAC holds a significant share of the overall biosurgery market.

Biosurgery Market

Applications in gynecological surgery, general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, reconstructive surgery, urological surgery, and thoracic surgery drive the growth of biosurgery market

Orthopedic Surgery

Orthopedic surgeries is one of those applications where the procedures are associated with significant blood loss owing to the dissection of bony and fibrotic tissues. Bleeding management and the effective regeneration of tissues and bones are the common challenges faced by orthopedic surgeons. Biosurgery products such as surgical sealants, hemostats, bone-graft substitutes, and soft-tissue repair products are some of the commonly used products to overcome these challenges.

Gynecological Surgery

Gynecological procedures such as myomectomies (surgical removal of uterine fibroids without the removal of the uterus), hysterectomies (surgical removal of the uterus), and surgeries for C-section requires biosurgery products. These products are used for controling surgical bleeding and related complications as well as sutures and hemoclips are the primary means of achieving hemostasis during these surgeries.

General Surgery

Biosurgery products are used in surgical procedures performed for the treatment of diseases involving the skin, soft tissues, and hernias. Of these, hernia repair, for inguinal, umbilical, hiatal, femoral, and incisional hernias, among other types, are among the most common. In this surgery, surgical sealants, surgical soft tissue meshes, adhesion barriers, staple line reinforcement agents, and hemostats are commonly used.

Cardiovascular Surgery

Biosurgery products for cardiovascular surgeries include coronary artery bypass grafting (CABG), congenital heart surgery, aortic anastomosis during CABG, and implantation of vascular prostheses. Owing to the complex challenges during procedures, hemostatic agents, sealants, and adhesion barriers, along with staple line reinforcement agents such as sutures, are commonly used in cardiovascular surgeries.

Neurological Surgery

Neurological surgeries such as spinal surgeries, neurovascular surgeries, surgeries to treat brain tumors, and surgeries to treat chronic strokes, among other procedures require biosurgery products. These products have maximum applications in neurological surgeries such as sealants and hemostats are used in adjuncts during surgeries, bone-graft substitutes are used to promote bone fusion in neurological surgeries and Cerebrospinal fluid (CSF) leaks are common complications in spinal surgeries, which sealants help resolve.

Reconstructive Surgery

Reconstructive surgeries are performed to treat body structures affected aesthetically and functionally by congenital defects, developmental abnormalities, trauma, infection, tumors, or diseases. These biosurgery products such as sealants, hemostats, soft-tissue patches/meshes, and staple line reinforcement agents have been used in various reconstructive surgeries, including plastic surgeries, face lifts, rhinoplasty, body contouring, breast surgeries (breast reconstruction & augmentation), burns, and craniofacial applications

Urological Surgery

Biosurgery products used in urological surgeries include surgical sealants, adhesion barriers, hemostatic agents, and soft-tissue meshes. These products serve as adjuncts to primary surgical therapy and aid in preventing surgical complications. These products has increasing applications in urological surgeries for the management of traumatic and iatrogenic urologic injuries (they are also used to promote optimal wound healing).

Thoracic Surgery

Biosurgery products, deal with complications such as prolonged air leaks, injuries to the surrounding blood vessels, and repeated buildup of fluids. The usage of biosurgery products helps in reducing the incidence of prolonged air leaks, enabling faster drain removal.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for biosurgery products?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

The price of biosurgery products is a major factor restraining the growth of the market. With the unfavorable reimbursement scenario, makes them unaffordable for a large section of the target patient population. The cost of surgical procedures has increased considerably over the years due to factors such as consolidation of healthcare providers, rising expenses owing to the use of complex medical procedures, changing government regulations, and constrained resources. This has adversely affecting the affordability of various surgical procedures for patients.

Key players in the market include Baxter (US), Johnson & Johnson (US), and Medtronic (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), MAQUET (Sweden), Cohera Medical (US), Hemostasis (US), Stryker (US), B.Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and prducts in the market.

Table of Contents

1 Biosurgery Market: Introduction (Page No. - 26)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Biosurgery Market: Research Methodology (Page No. - 30)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Biosurgery Market: Executive Summary (Page No. - 40)

4 Biosurgery Market: Premium Insights (Page No. - 47)
    4.1 Biosurgery Market: Overview
    4.2 APAC: Biosurgery Market, By Type & Country (2017)
    4.3 Geographic Snapshot of the Biosurgery Market (2017)
    4.4 Geographic Mix: Biosurgery Market, 2016 — 2023 (USD Million)
    4.5 Biosugery Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)

5 Biosurgery Market: Overview (Page No. - 51)
    5.1 Introduction
    5.2 Drivers
           5.2.1 Rising Geriatric Population
           5.2.2 Increasing Volume of Surgeries and Prevalence of Severe Trauma Injuries
           5.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products
           5.2.4 Rising Need for Effective Blood Loss Management in Patients
    5.3 Market Restraints
           5.3.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures
    5.4 Market Opportunities
           5.4.1 Untapped Emerging Markets
    5.5 Market Challenges
           5.5.1 Stringent Regulatory Framework
           5.5.2 Requirement of Skilled Personnel for the Effective Use of Biosurgery Products

6 Industry Insights (Page No. - 57)
    6.1 Industry Trends
           6.1.1 Increasing Market Consolidation
           6.1.2 Rising Focus on Product Developments & Launches
           6.1.3 Growing Demand for Dental Bone-Graft Substitutes
           6.1.4 Growing Preference for Gelatin-Based Adhesives & Hydrogels in Surgical Procedures
    6.2 Regulatory Analysis
           6.2.1 North America
                    6.2.1.1 US
                    6.2.1.2 Canada
           6.2.2 Europe
           6.2.3 APAC
                    6.2.3.1 Japan
                    6.2.3.2 China
                    6.2.3.3 India
    6.3 Strategic Benchmarking
           6.3.1 Biosurgery Market: Product Portfolio Analysis
           6.3.2 Natural/Biological Sealants & Adhesives: Product Portfolio Analysis
           6.3.3 Synthetic & Semisynthetic Sealants & Adhesives: Product Portfolio Analysis
           6.3.4 Hemostatic Agents: Product Portfolio Analysis
           6.3.5 Adhesion Barriers: Product Portfolio Analysis
           6.3.6 Soft-Tissue Attachments: Product Portfolio Analysis
           6.3.7 Bone-Graft Substitutes : Product Portfolio Analysis

7 Biosurgery Market, By Product (Page No. - 74)
    7.1 Introduction
    7.2 Bone-Graft Substitutes
           7.2.1 Demineralized Bone Matrix
           7.2.2 Synthetic Bone Grafts
           7.2.3 Bone Morphogenetic Proteins
           7.2.4 Other Bone-Graft Substitutes
    7.3 Soft-Tissue Attachments
           7.3.1 Synthetic Meshes
           7.3.2 Biological Meshes
                    7.3.2.1 Allografts
                    7.3.2.2 Xenografts
    7.4 Hemostatic Agents
           7.4.1 Thrombin-Based Hemostatic Agents
           7.4.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents
           7.4.3 Combination Hemostatic Agents
    7.5 Surgical Sealants and Adhesives
           7.5.1 Natural/Biological Sealants and Adhesives
                    7.5.1.1 Natural/Biological Sealants and Adhesives, By Type
                               7.5.1.1.1 Fibrin Sealants
                               7.5.1.1.2 Collagen-Based Sealants
                               7.5.1.1.3 Gelatin-Based Sealants
                               7.5.1.1.4 Albumin-Based Sealants
                               7.5.1.1.5 Other Natural/Biological Sealants
                    7.5.1.2 Natural/Biological Sealants and Adhesives, By Origin
                               7.5.1.2.1 Human Blood-Based Sealants and Adhesives
                               7.5.1.2.2 Animal-Based Sealants and Adhesives
           7.5.2 Synthetic and Semi-Synthetic Sealants and Adhesives
                    7.5.2.1 Peg Hydrogels
                    7.5.2.2 Cyanoacrylate-Based Sealants and Adhesives
                    7.5.2.3 Urethane-Based Sealants and Adhesives
                    7.5.2.4 Other Synthetic and Semi-Synthetic Sealants and Adhesives
    7.6 Adhesion Barriers
           7.6.1 Synthetic Adhesion Barriers
                    7.6.1.1 Hyaluronic Acid-Based Adhesion Barriers
                    7.6.1.2 Regenerated Cellulose-Based Adhesion Barriers
                    7.6.1.3 Peg-Based Adhesion Barriers
                    7.6.1.4 Ther Synthetic Adhesion Barriers
           7.6.2 Natural Adhesion Barriers
                    7.6.2.1 Collagen & Protein Adhesion Barriers
                    7.6.2.2 Fibrin-Based Adhesion Barriers
    7.7 Staple-Line Reinforcement Agents

8 Biosurgery Market, By Application (Page No. - 134)
    8.1 Introduction
    8.2 Orthopedic Surgery
    8.3 General Surgery
    8.4 Neurological Surgery
    8.5 Cardiovascular Surgery
    8.6 Reconstructive Surgery
    8.7 Gynecological Surgery
    8.8 Urological Surgery
    8.9 Thoracic Surgery

9 Biosurgery Market, By Region (Page No. - 147)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Latin America
           9.5.1 Brazil
           9.5.2 Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East and Africa

10 Biosurgery Market: Competitive Landscape (Page No. - 252)
     10.1 Overview
     10.2 Market Share Analysis
             10.2.1 Surgical Sealants and Adhesives
             10.2.2 Hemostatic Agents
             10.2.3 Bone-Graft Substitutes
             10.2.4 Adhesion Barriers
             10.2.5 Soft-Tissue Attachments
     10.3 Competitive Situations and Trends
             10.3.1 Product Launches and Approvals
             10.3.2 Agreements and Partnerships
             10.3.3 Acquisitions
             10.3.4 Expansions

11 Company Profiles (Page No. - 263)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Baxter International, Inc.
     11.2 B.Braun Melsungen AG
     11.3 C.R. Bard
     11.4 Johnson & Johnson
     11.5 Medtronic, PLC.
     11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
     11.7 Cohera Medical Inc.
     11.8 Integra Lifesciences Holdings Corporation
     11.9 Commonwealth Serum Laboratories (CSL)
     11.10 Hemostasis, LLC
     11.11 Sanofi
     11.12 Pfizer Inc.
     11.13 Stryker Corporation
     11.14 Cryolife, Inc.

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 303)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Report
     12.7 Author Details


List of Tables (352 Tables)

Table 1 Standard Currency Conversion Rates
Table 2 Biosurgery Market Snapshot
Table 3 Biosurgery Market Dynamics: Impact Analysis
Table 4 Percentage Increase in the Number of Surgical Procedures Performed in the US
Table 5 Major Acquisitions in the Biosurgery Market (2015–2017)
Table 6 Number of Product Launches By Key Players (2015–2018)
Table 7 Indicative List of Regulatory Authorities Governing Medical Devices
Table 8 Stringency of Regulations for Biosurgery Products, By Country
Table 9 Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 10 Biosurgery Market for Bone-Graft Substitutes, By Type, 2016–2023 (USD Million)
Table 11 Biosurgery Market for Bone-Graft Substitutes, By Country, 2016–2023 (USD Million)
Table 12 Major Products in the DBM Market
Table 13 Demineralized Bone Matrix Market, By Country, 2016–2023 (USD Million)
Table 14 Major Products in the Synthetic Bone Grafts Market
Table 15 Synthetic Bone Grafts Market, By Country, 2016–2023 (USD Million)
Table 16 Major Products in the Bone Morphogenetic Proteins Market
Table 17 Bone Morphogenetic Proteins Market, By Country, 2016–2023 (USD Million)
Table 18 Major Products in the Other Bone-Graft Substitutes Market
Table 19 Other Bone-Graft Substitutes Market, By Country, 2016–2023 (USD Million)
Table 20 Biosurgery Market for Soft-Tissue Attachments, By Type, 2016-2023 (USD Million)
Table 21 Biosurgery Market for Soft-Tissue Attachments, By Country, 2016-2023 (USD Million)
Table 22 Major Products in the Synthetic Meshes Market
Table 23 Synthetic Meshes Market, By Country, 2016–2023 (USD Million)
Table 24 Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 25 Biological Meshes Market, By Country, 2016–2023 (USD Million)
Table 26 Allografts Market, By Country, 2016–2023 (USD Million)
Table 27 Xenografts Market, By Country, 2016–2023 (USD Million)
Table 28 Biosurgery Market for Hemostatic Agents, By Type, 2016-2023 (USD Million)
Table 29 Biosurgery Market for Hemostatic Agents, By Country, 2016-2023 (USD Million)
Table 30 Major Products in the Thrombin-Based Hemostatic Agents Market
Table 31 Thrombin-Based Hemostatic Agents Market, By Country, 2016-2023 (USD Million)
Table 32 Major Products in the Oxidized Regenerated Cellulose-Based Hemostatic Agents Market
Table 33 Oxidized Regenerated Cellulose-Based Hemostatic Agents Market, By Country, 2016-2023 (USD Million)
Table 34 Major Products in the Combination Hemostatic Agents
Table 35 Combination Hemostats Market, By Country, 2016-2023 (USD Million)
Table 36 Biosurgery Market for Surgical Sealants and Adhesives, By Type, 2016-2023 (USD Million)
Table 37 Biosurgery Market for Surgical Sealants and Adhesives Market, By Country, 2016–2023 (USD Million)
Table 38 Biosurgery Market for Natural/Biological Sealants and Adhesives, By Type, 2016–2023 (USD Million)
Table 39 Biosurgery Market for Natural/Biological Sealants and Adhesives, By Country, 2016–2023 (USD Million)
Table 40 Major Products in the Fibrin Sealants Market
Table 41 Fibrin Sealants Market, By Country, 2016–2023 (USD Million)
Table 42 Major Products in the Collagen Based-Sealants Market
Table 43 Collagen-Based Sealants Market, By Country, 2016–2023 (USD Million)
Table 44 Major Products in the Gelatin Based-Sealants Market
Table 45 Gelatin-Based Sealants Market , By Country, 2016–2023 (USD Million)
Table 46 Major Products in the Albumin Based-Sealants Market
Table 47 Albumin-Based Sealants Market, By Country, 2016–2023 (USD Million)
Table 48 Other Natural/Biological Sealants Market, By Country, 2016–2023 (USD Million)
Table 49 Natural/Biological Sealants and Adhesives Market, By Origin, 2016-2023 (USD Million)
Table 50 Human Blood-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 51 Animal-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 52 Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 53 Synthetic and Semi-Synthetic Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 54 Major Products in the Peg Hydrogel-Based Sealants and Adhesives Market
Table 55 Peg Hydrogel-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 56 Major Products in the Cyanoacrylate-Based Sealants and Adhesives Market
Table 57 Cyanoacrylate-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 58 Major Urethane-Based Sealants and Adhesives in the Market
Table 59 Urethane-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 60 Other Synthetic and Semi-Synthetic Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 61 Biosurgery Market for Adhesion Barriers, By Type, 2016-2023 (USD Million)
Table 62 Biosurgery Market for Adhesion Barriers, By Country, 2016-2023 (USD Million)
Table 63 Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 64 Synthetic Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 65 Major Products in the Hyaluronic Acid-Based Adhesion Barriers Market
Table 66 Hyaluronic Acid-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 67 Major Products in the Regenerated Cellulose-Based Adhesion Barriers Market
Table 68 Regenerated Cellulose-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 69 Major Products in the Peg-Based Adhesion Barriers Market
Table 70 Peg-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 71 Major Products in the Other Synthetic Adhesion Barriers Market
Table 72 Other Synthetic Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 73 Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 74 Natural Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 75 Major Products in the Collagen and Protein Adhesion Barriers Market
Table 76 Collagen and Protein Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 77 Major Products in the Fibrin-Based Adhesion Barriers Market
Table 78 Fibrin-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 79 Major Products in the Staple-Line Reinforcement Agents Market
Table 80 Biosurgery Market for Staple-Line Reinforcement Agents, By Country, 2016–2023 (USD Million)
Table 81 Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 82 Orthopedic Surgery Market, By Country, 2016–2023 (USD Million)
Table 83 General Surgery Market, By Country, 2016–2023 (USD Million)
Table 84 Neurological Surgery Market, By Country, 2016–2023 (USD Million)
Table 85 Cardiovascular Surgery Market, By Country, 2016–2023 (USD Million)
Table 86 Reconstructive Surgery Market, By Country, 2016–2023 (USD Million)
Table 87 Countries With the Highest C-Section Rate (2015)
Table 88 Gynecological Surgery Market, By Country, 2016–2023 (USD Million)
Table 89 Urological Surgery Market, By Country, 2016–2023 (USD Million)
Table 90 Thoracic Surgery Market, By Country, 2016–2023 (USD Million)
Table 91 Biosurgery Market, By Region, 2016–2023 (USD Million)
Table 92 North America: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 93 North America: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 94 North America: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 95 North America: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 96 North America: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 97 North America: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 98 North America: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 99 North America: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 100 North America: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 101 North America: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 102 North America: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 103 North America: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 104 North America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 105 US: Key Macroindicators for the Biosurgery Market
Table 106 US: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 107 US: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 108 US: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 109 US: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 110 US: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 111 US: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 112 US: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 113 US: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 114 US: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 115 US: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 116 US: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 117 US: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 118 Canada: Key Macroindicators for the Biosurgery Market
Table 119 Canada: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 120 Canada: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 121 Canada: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 122 Canada: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 123 Canada: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 124 Canada: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 125 Canada: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 126 Canada: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 127 Canada: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 128 Canada: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 129 Canada: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 130 Canada: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 131 Europe: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 132 Europe: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 133 Europe: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 134 Europe: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 135 Europe: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 136 Europe: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 137 Europe: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 138 Europe: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 139 Europe: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 140 Europe: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 141 Europe: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 142 Europe: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 143 Europe: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 144 Germany: Key Macroindicators for the Biosurgery Market
Table 145 Germany: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 146 Germany: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 147 Germany: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 148 Germany: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 149 Germany: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 150 Germany: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 151 Germany: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 152 Germany: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 153 Germany: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 154 Germany: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 155 Germany: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 156 Germany: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 157 UK: Key Macroindicators for the Biosurgery Market
Table 158 UK: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 159 UK: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 160 UK: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 161 UK: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 162 UK: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 163 UK: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 164 UK: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 165 UK: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 166 UK: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 167 UK: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 168 UK: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 169 UK: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 170 France: Key Macroindicators for the Bosurgery Market
Table 171 France: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 172 France: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 173 France: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 174 France: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 175 France: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 176 France: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 177 France: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 178 France: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 179 France: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 180 France: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 181 France: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 182 France: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 183 Italy: Key Macroindicators for the Biosurgery Market
Table 184 Italy: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 185 Italy: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 186 Italy: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 187 Italy: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 188 Italy: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 189 Italy: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 190 Italy: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 191 Italy: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 192 Italy: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 193 Italy: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 194 Italy: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 195 Italy: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 196 Spain: Key Macroindicators for the Biosurgery Market
Table 197 Spain: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 198 Spain: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 199 Spain: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 200 Spain: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 201 Spain: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 202 Spain: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 203 Spain: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 204 Spain: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 205 Spain: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 206 Spain: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 207 Spain: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 208 Spain: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 209 RoE: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 210 RoE: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 211 RoE: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 212 RoE: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 213 RoE: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 214 RoE: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 215 RoE: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 216 RoE: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 217 RoE: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 218 RoE: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 219 RoE: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 220 RoE: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 221 APAC: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 222 APAC: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 223 APAC: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 224 APAC: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 225 APAC: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 226 APAC: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 227 APAC: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 228 APAC: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 229 APAC: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 230 APAC: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 231 APAC: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 232 APAC: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 233 APAC: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 234 Japan: Key Macroindicators for the Biosurgery Market
Table 235 Japan: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 236 Japan: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 237 Japan: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 238 Japan: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 239 Japan: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 240 Japan: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 241 Japan: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 242 Japan: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 243 Japan: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 244 Japan: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 245 Japan: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 246 Japan: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 247 China: Key Macroindicators for the Biosurgery Market
Table 248 China: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 249 China: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 250 China: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 251 China: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 252 China: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 253 China: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 254 China: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 255 China: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 256 China: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 257 China: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 258 China: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 259 China: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 260 India: Key Macroindicators for the Biosurgery Market
Table 261 India: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 262 India: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 263 India: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 264 India: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 265 India: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 266 India: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 267 India: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 268 India: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 269 India: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 270 India: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 271 India: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 272 India: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 273 RoAPAC: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 274 RoAPAC: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 275 RoAPAC: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 276 RoAPAC: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 277 RoAPAC: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 278 RoAPAC: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 279 RoAPAC: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 280 RoAPAC: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 281 RoAPAC: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 282 RoAPAC: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 283 RoAPAC: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 284 RoAPAC: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 285 Latin America: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 286 Latin America: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 287 Latin America: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 288 Latin America: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 289 Latin America: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 290 Latin America: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 291 Latin America: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 292 Latin America: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 293 Latin America: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 294 Latin America: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 295 Latin America: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 296 Latin America: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 297 Latin America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 298 Brazil: Key Macroindicators for the Biosurgery Market
Table 299 Brazil: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 300 Brazil: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 301 Brazil: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 302 Brazil: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 303 Brazil: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 304 Brazil: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 305 Brazil: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 306 Brazil: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 307 Brazil: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 308 Brazil: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 309 Brazil: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 310 Brazil: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 311 Mexico: Key Macroindicators for the Biosurgery Market
Table 312 Mexico: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 313 Mexico: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 314 Mexico: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 315 Mexico: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 316 Mexico: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 317 Mexico: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 318 Mexico: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 319 Mexico: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 320 Mexico: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 321 Mexico: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 322 Mexico: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 323 Mexico: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 324 RoLA: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 325 RoLA: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 326 RoLA: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 327 RoLA: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 328 RoLA: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 329 RoLA: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 330 RoLA: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 331 RoLA: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 332 RoLA: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 333 RoLA: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 334 RoLA: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 335 Rest of Latin America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 336 Middle East and Africa: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 337 Middle East and Africa: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 338 Middle East and Africa: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 339 Middle East and Africa: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 340 Middle East and Africa: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 341 Middle East and Africa: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 342 Middle East and Africa: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 343 Middle East and Africa: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 344 Middle East and Africa: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 345 Middle East and Africa: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 346 Middle East and Africa: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 347 Middle East and Africa: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 348 Growth Strategy Matrix (2015–2018)
Table 349 Product Launches, 2015–2018
Table 350 Agreements and Partnerships, 2015-2018
Table 351 Acquisitions, 2015-2018
Table 352 Expansions, 2015-2018
 
 
List of Figures (56 Figures)
 
Figure 1 Biosurgery Market
Figure 2 Biosurgery Market: Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews (Supply Side): By Company Type, Designation, and Region
Figure 5 Breakdown of Primary Interviews (Demand Side): By End User and Region
Figure 6 Data Triangulation Methodology
Figure 7 Biosurgery Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Natural/Biological Sealants Market, By Type, 2018 vs 2023 (USD Million)
Figure 9 Synthetic and Semi-Synthetic Sealants Market, By Type, 2018 vs 2023 (USD Million)
Figure 10 Hemostats Market, By Type, 2018 vs 2023 (USD Million)
Figure 11 Soft-Tissue Attachments Market, By Type, 2018 vs 2023 (USD Million)
Figure 12 Adhesion Barrier Market, By Type, 2018 vs 2023 (USD Million)
Figure 13 Synthetic Adhesion Barrier Market, By Type, 2018 vs 2023 (USD Million)
Figure 14 Bone-Graft Substitute Market, By Type, 2018 vs 2023 (USD Million)
Figure 15 Biosurgery Market, By Application, 2018 vs 2023 (USD Million)
Figure 16 Biosurgery Market Share, By Region
Figure 17 Increase in the Volume of Surgeries to Drive Market Growth
Figure 18 Bone-Graft Substitutes Held the Largest Share of the APAC Market in 2017
Figure 19 The US Accounted for the Largest Share of the Biosurgery Market in 2017
Figure 20 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 21 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 22 Growth in Geriatric Population, By Region, 2015–2050
Figure 23 Increasing Market Consolidation & Rising Focus on Product Developments are the Major Trends in the Biosurgery Market
Figure 24 Product Launches and Approvals - Key Growth Strategy Adopted By Major Players in the Biosurgery Market (2015–2018)
Figure 25 Premarket Notification: 510(K) Approval for Medical Devices
Figure 26 Biosurgery Market: Vendor Benchmarking
Figure 27 Bone-Graft Substitutes Segment to Dominate the Biosurgery Market in 2018
Figure 28 Demineralized Bone Matrix Segment to Grow at the Highest CAGR During the Forecast Period
Figure 29 Synthetic Meshes Segment to Grow at the Highest CAGR
Figure 30 Combination Hemostats Segment to Grow at the Highest CAGR During the Forecast Period
Figure 31 Synthetic and Semi-Synthetic Sealants Segment to Grow at the Highest CAGR During the Forecast Period
Figure 32 Human Blood-Based Sealants and Adhesives to Dominate the Natural/Biological Sealants & Adhesives Market
Figure 33 Synthetic Adhesion Barriers to Grow at the Highest CAGR During the Forecast Period
Figure 34 Orthopedic Surgery to Dominate the Biosurgery Applications Market During the Forecast Period
Figure 35 Geographic Snapshot: Markets in Asia Pacific are Emerging Hotspots
Figure 36 North America: Biosurgery Market Snapshot
Figure 37 Europe: Biosurgery Market Snapshot
Figure 38 APAC: Biosurgery Market Snapshot
Figure 39 Key Developments of Major Players Between January 2015 and March 2018
Figure 40 Surgical Sealants and Adhesives Market Share Analysis, By Key Player, 2017
Figure 41 Hemostatic Agents Market Share Analysis, By Key Player, 2017
Figure 42 Bone-Graft Substitutes Market Share Analysis, By Key Player, 2017
Figure 43 Adhesion Barriers Market Share Analysis, By Key Player, 2017
Figure 44 Soft-Tissue Attachments Market Share Analysis, By Key Player, 2017
Figure 45 Baxter International, Inc.: Company Snapshot (2017)
Figure 46 B.Braun Melsungen AG : Company Snapshot (2017)
Figure 47 C.R. Bard: Company Snapshot (2016)
Figure 48 Johnson & Johnson: Company Snapshot (2017)
Figure 49 Medtronic: Company Snapshot (2017)
Figure 50 Getinge Group: Company Snapshot (2017)
Figure 51 Integra Lifesciences Holdings Corporation: Company Snapshot (2017)
Figure 52 Commonwealth Serum Laboratories: Company Snapshot (2017)
Figure 53 Sanofi: Company Snapshot (2017)
Figure 54 Pfizer Inc.: Company Snapshot (2017)
Figure 55 Stryker Corporation: Company Snapshot (2017)
Figure 56 Cryolife: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3554
Published ON
Jul, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biosurgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved